
Medicare finally pays for prescription digital therapeutics, and the test begins
Dr. Dereck Mush, MD, MBANo. 0 Founders & operators
Co-Founder and CEO, TwoStep Therapeutics • United States
Stanford-trained scientist leading a new class of multi-specific peptide-drug conjugates.
Find on LinkedInMiller co-founded TwoStep Therapeutics with Stanford faculty including Nobel laureate Carolyn Bertozzi, and in September 2026 announced a 62.5 million dollar Series A and FDA clearance to begin first-in-human trials of its lead oncology program.
Stanford-trained scientist leading a new class of multi-specific peptide-drug conjugates.
Miller co-founded TwoStep Therapeutics with Stanford faculty including Nobel laureate Carolyn Bertozzi, and in September 2026 announced a 62.5 million dollar Series A and FDA clearance to begin first-in-human trials of its lead oncology program.
Loading the full dossier
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
How much the audience actually reacts, comments, shares and subscribes.
Clinical, research, operating or investing track record behind the commentary.
Publishing cadence and how reliably they show up with original work.
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Change, add or remove details on this profile. Our desk reviews every request.
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring